About Collegium Pharmaceutical Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.collegiumpharma.com/
Frequently Asked Questions
What is the 52-week range for COLL?
The 52-week high is $50.787 and the 52-week low is $21.43.
What is the P/E ratio for COLL?
The Price to Earnings (P/E) ratio is 15.02.
What is the dividend yield for COLL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 15.96%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 5.93%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 4.85.
Analyst Recommendation Trends
Wall Street analyst consensus for COLL over the last few months:
Latest COLL News
3 Healthcare Stocks That Concern Us
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.7% gain over the past six months, beating the S&P 500 by 25.6 percentage points.
3 Value Stocks That Fall Short
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.
Oppenheimer Initiates Coverage On Collegium Pharmaceutical with Outperform Rating, Announces Price Target of $50
Oppenheimer analyst Les Sulewski initiates coverage on Collegium Pharmaceutical (NASDAQ:COLL) with a Outperform rating and announces Price Target of $50.
1 Oversold Stock Ready to Bounce Back and 2 We Find Risky
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they’re witnessing fire sales or falling knives.
1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Collegium Pharmaceutical, Inc. (COLL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Collegium Pharmaceutical, Inc. (COLL) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 4:05 PM EDTCompany ParticipantsVikram...
Truist Securities Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $49
Truist Securities analyst Alexander Xenakis maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and lowers the price target from $58 to $49.
Leerink Partners Initiates Coverage On Collegium Pharmaceutical with Outperform Rating, Announces Price Target of $45
Leerink Partners analyst Daniel Clark initiates coverage on Collegium Pharmaceutical (NASDAQ:COLL) with a Outperform rating and announces Price Target of $45.
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that its management will participate in the following investor conferences: Morgan Stanley 24th Annual Global Healthcare ConferenceFireside Chat Date and Time: Tuesday, September 15, 2026, at 4:05 p.m. ETNew York, NY H.C. Wainwright 28th Annual Global
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In Q3
Healthcare stocks UTHR, COLL and AHG show oversold RSI levels near or below 30, potentially offering undervalued buying opportunities.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-08 | SANTINI GINO | -8,700 | - | - |
| 2026-06-08 | SANTINI GINO | +8,700 | $16.49 | $143,463 |
| 2026-05-18 | Freund John Gordon | -20 | $34.05 | $681 |
| 2026-05-15 | Freund John Gordon | -8,700 | - | - |
| 2026-05-15 | Freund John Gordon | -4,127 | $34.54 | $142,547 |
| 2026-05-15 | Freund John Gordon | +8,700 | $16.49 | $143,463 |
| 2026-05-14 | Glancy Donovan Michael | +17,482 | - | - |
| 2026-05-14 | Balice-Gordon Rita J. | +8,741 | - | - |
| 2026-05-14 | Paya Carlos V | +8,741 | - | - |
| 2026-05-14 | Lurker Nancy | +8,741 | - | - |
| 2026-05-14 | Freund John Gordon | +8,741 | - | - |
| 2026-05-14 | SANTINI GINO | +8,741 | - | - |
| 2026-05-14 | BOHLIN GAREN G | +8,741 | - | - |
| 2026-05-13 | Lurker Nancy | -4,500 | $35.9691 | $161,861 |
| 2026-05-11 | BOHLIN GAREN G | -8,700 | - | - |
| 2026-05-11 | BOHLIN GAREN G | -8,700 | $37.1829 | $323,491 |
| 2026-05-11 | BOHLIN GAREN G | +8,700 | $16.49 | $143,463 |
| 2026-03-18 | Dieter David | -13,976 | $34.9241 | $488,099 |
| 2026-03-17 | Dieter David | -8,840 | $35.72 | $315,765 |
| 2026-03-09 | Dieter David | -6,224 | $36.65 | $228,110 |
| 2026-03-03 | Dreyer Scott | -3,559 | $40.9889 | $145,879 |
| 2026-03-03 | Dreyer Scott | -46,417 | $40.3636 | $1,873,557 |
| 2026-02-10 | Dieter David | -2,781 | $46.75 | $130,012 |
| 2026-02-10 | Dieter David | +9,005 | - | - |
| 2026-02-10 | Dieter David | +22,194 | - | - |
| 2026-02-10 | Tupper Colleen | -26,679 | $46.75 | $1,247,243 |
| 2026-02-10 | Tupper Colleen | -11,861 | $46.75 | $554,502 |
| 2026-02-10 | Tupper Colleen | +32,734 | - | - |
| 2026-02-10 | Tupper Colleen | +26,421 | - | - |
| 2026-02-10 | Smith Thomas B | -11,538 | $46.75 | $539,402 |
| 2026-02-10 | Smith Thomas B | -5,897 | $46.75 | $275,685 |
| 2026-02-10 | Smith Thomas B | +22,774 | - | - |
| 2026-02-10 | Smith Thomas B | +14,268 | - | - |
| 2026-02-10 | Dreyer Scott | -21,615 | $46.75 | $1,010,501 |
| 2026-02-10 | Dreyer Scott | -9,977 | $46.75 | $466,425 |
| 2026-02-10 | Dreyer Scott | +30,702 | - | - |
| 2026-02-10 | Dreyer Scott | +19,023 | - | - |
| 2026-02-10 | Karnani Vikram | -11,296 | $46.75 | $528,088 |
| 2026-02-10 | Karnani Vikram | +32,531 | - | - |
| 2026-02-10 | Karnani Vikram | +79,264 | - | - |
| 2025-12-08 | Dreyer Scott | -17,600 | - | - |
| 2025-12-08 | Dreyer Scott | -6,475 | $48.6617 | $315,085 |
| 2025-12-08 | Dreyer Scott | -11,125 | $47.8895 | $532,771 |
| 2025-12-08 | Dreyer Scott | +17,600 | $15.9 | $279,840 |
| 2025-12-05 | Balice-Gordon Rita J. | -3,650 | $47.0338 | $171,673 |
| 2025-11-12 | Karnani Vikram | -8,983 | $47.35 | $425,345 |
| 2025-11-12 | Fallon John A. | -19,853 | - | - |
| 2025-11-12 | Fallon John A. | -15,000 | - | - |
| 2025-11-12 | Fallon John A. | -34,853 | $47.2136 | $1,645,536 |
| 2025-11-12 | Fallon John A. | +19,853 | $9.33 | $185,228 |
| 2025-11-12 | Fallon John A. | +15,000 | $16.49 | $247,350 |
| 2025-11-06 | Tupper Colleen | -4,858 | $41.2756 | $200,517 |
| 2025-11-06 | Tupper Colleen | -25,142 | $40.3801 | $1,015,236 |